Take a portfolio health check & monitor all your assets in the one convenient location.
Free Portfolio Manager

Latest Research See more

CYBG: Interim result 2017

Despite Brexit and economic uncertainty, CYBG's results continue to improve since being spun off from NAB.
5d ago
CYB

Cochlear's secret sauce

An industry-leading research budget isn't enough for Cochlear to do well – it must also time the market.
14h ago
COH

Cease Coverage on MAH

Macmahon has been a mildly successful recommendation. It's time to end coverage.
14h ago
MAH

Current Recommendations

Stock Price Source Buy/Hold/Sell
ABC $5.32
FPH $9.49
DLX $7.04

InvestSMART currently has 10 Buy, 122 Hold & 41 Sell recommendations.

Join now

Intelligent Investor Logo Latest from Intelligent Investor See more

Eureka Report Logo Latest from Eureka Report See more

Markets Today See more